Kontakt 2007, 9(2):425-426 | DOI: 10.32725/kont.2007.065

Proč rakovinná buňka nestárne?Popularizace vědy

Jiří Patočka*, Zdeněk Hon
Jihočeská univerzita v Českých Budějovicích, Zdravotně sociální fakulta, katedra radiologie a toxikologie

Received: August 6, 2007; Accepted: October 22, 2007; Published: December 21, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Patočka J, Hon Z. Proč rakovinná buňka nestárne? Kontakt. 2007;9(2):425-426. doi: 10.32725/kont.2007.065.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. CAMPISI, J.: The biology of replicative senescence. Eur J Cancer 1997. Vol. 33, no 5, s. 703-709. Go to original source... Go to PubMed...
    2. HARLEY, C. B., FUTCHER, A. B., GREIDER, C. W.: Telomeres shorten during ageing of human fibroblasts. Nature 1990. Vol. 345, no 6274, s. 458-460. Go to original source... Go to PubMed...
    3. HIYAMA, E., HIYAMA, K.: Telomerase as tumor marker. Cancer Lett 2003. Vol. 194, no 2, s. 221-233. Go to original source... Go to PubMed...
    4. HOLT, S. E., WRIGHT, W. E.., SHAY, J. W.: Multiple pathways for the regulation of telomerase activity. Eur J Cancer 1997. Vol. 33, no 5, s. 761-766. Go to original source... Go to PubMed...
    5. INCLES, C. M., SCHULTES, C. M., NEIDLE, S.: Telomerase inhibitors in cancer therapy: current status and future directions. Curr Opin Investig Drugs. 2003. Vol. 4, no 6, s. 675-685. Go to PubMed...
    6. KIM, M. Y. et al.: Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex. J Am Chem Soc. 2002. Vol. 124, no 10, s. 2098-2099. Go to original source... Go to PubMed...
    7. PATOČKA, J.: Telomestatin - nový přístup v terapii rakoviny. Server TOXICOLOGY https://toxicology.emtrading.cz/modules.php?name=News&file=article&sid=132&mode=nocommentsℴ=0&thold=1
    8. RHYU, M. S.: Telomeres, telomerase, and immortality. J Natl Cancer Inst. 1995. Vol. 87, no 12, s. 884-894. Go to original source... Go to PubMed...
    9. SHIN-YA, K. et al.: Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J Am Chem Soc. 2001. Vol. 123, no 6, s. 1262-1263. Go to original source... Go to PubMed...
    10. TAUCHI, T. et al.: Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways. Oncogene. 2003. Vol. 22, no 34, s. 5338-5347. Go to original source... Go to PubMed...

    Return to the content